New blood tests aim to Fine-Tune hemophilia care
NCT ID NCT02453542
Summary
This study aims to find better ways to monitor the effectiveness of treatments for hemophilia patients who have developed inhibitors, which make standard treatments less effective. Researchers will test new blood analysis methods on 20 patients over two years to see if these tests can more accurately show how well the treatments are working. The goal is to improve patient safety and make treatments more effective by providing doctors with better tools for monitoring.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Karolinska University Hospital
RECRUITINGSolna, Stockholm County, 17176, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.